NPPB and type 2 diabetes mellitus: Recent evidence of the discriminatory strength of NT-proBNP as an independent predictor of death and CV outcomes calls attention to the possibility of broader use of this simple, easy to measure, and widely available resource to improve risk stratification, for patients with T2DM.